APOL2 Stabilizes Ku80 to Confer NHEJ‐Mediated Radioresistance in Gastric Cancer
Advanced Science · 2025
DOI: 10.1002/advs.202506294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Dan Zu und 23 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Tianjin University, Tianjin, 300100, China. Hauptthemen laut MEDLINE: Ku Autoantigen, Stomach Neoplasms, Radiation Tolerance, DNA End-Joining Repair. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Zhejiang Medical and Health Science and Technology Program.
Abstract (Originalsprache)
Radiotherapy is one of the most important adjuvant treatment methods for gastric cancer (GC). However, radioresistance remains a major clinical obstacle. In this study, APOL2 is identified as a key player in promoting non‐homologous end joining (NHEJ)‐mediated double‐strand break (DSB) repair and enhancing radioresistance in GC. Bioinformatics and clinical data revealed that high APOL2 expression is correlated with poor prognosis in GC patients. Functional experiments showed that APOL2 overexpression enhances genomic stability by accelerating DSB repair via the NHEJ pathway, while APOL2 knockout impairs repair capacity. Mechanistically, APOL2 binds to and stabilizes Ku80 by enhancing USP7‐mediated deubiquitylation, thereby increasing Ku80 protein levels to promote NHEJ repair, ultimately conferring radioresistance. Moreover, high‐throughput screening identified formononetin (FN) as a small molecule capable of disrupting the APOL2‐Ku80 interaction, thereby restoring radiosensitivity in GC cells. Our findings underscore the role of APOL2 in mediating radioresistance through Ku80 stabilization and highlight FN as a potential therapeutic agent to counteract radioresistance in GC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Tianjin University, Tianjin, 300100, China.
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China.
- Postgraduate training base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, 310022, China.
- Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province, Hangzhou, 310022, China.
- Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou, 310022, China.
- Hangzhou Medical College, Hangzhou, 310013, China.
ORCID-Profile: Xiangdong Cheng
Förderung
- Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Zhejiang Medical and Health Science and Technology Program
- Beijing Science and Technology Innovation Medical Development Foundation
- Key Laboratory of Prevention, Diagnosis, and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Zu, D., Bao, Q., He, H., Zhong, Y., Deng, M., Hu, Y., Zhang, C., Liang, C., Huang, Y., Liu, H., Li, X., He, Y., Luo, G., Wu, W., Guan, F., Xu, S., Liu, M., Bacolla, A., Jing, J., …, & Cheng, X. (2025). APOL2 Stabilizes Ku80 to Confer NHEJ‐Mediated Radioresistance in Gastric Cancer. Advanced Science. https://doi.org/10.1002/advs.202506294
Vancouver
Zu D, Bao Q, He H, Zhong Y, Deng M, Hu Y, et al. APOL2 Stabilizes Ku80 to Confer NHEJ‐Mediated Radioresistance in Gastric Cancer. Advanced Science. 2025. doi:10.1002/advs.202506294
BibTeX
@article{Zu2025,
author = {Zu, Dan and Bao, Qimei and He, Hanyi and Zhong, Yuke and Deng, Mingcong and Hu, Yangchan and Zhang, Chunkai and Liang, Chen and Huang, Yixing and Liu, Haidong and Li, Xiao and He, Yanhua and Luo, Guoyan and Wu, Weixin and Guan, Fenghui and Xu, Shengfeng and Liu, Min and Bacolla, Albino and Jing, Ji and Du, Yian and Tainer, John A and Shi, Yin and Ye, Zu and Cheng, Xiangdong},
title = {APOL2 Stabilizes Ku80 to Confer NHEJ‐Mediated Radioresistance in Gastric Cancer},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202506294}
}
EUVIMED